Publication date: Available online 5 October 2026 Source: Clinical Genitourinary Cancer Author(s): Csilla Olah, Dániel Juhász, Bálint Dér, Vanda Selmeczi, Michael Rink, Margit Fisch, András Kiss, Boris Hadaschik, Péter Nyirády, Henning Reis, Tibor Szarvas
Expression of Antibody–Drug Conjugate Targets in Urachal and Primary Bladder Adenocarcinomas. // Clinical Genitourinary Cancer. – URL: https://www.sciencedirect.com/science/article/pii/S1558767326001904?dgcid=rss_sd_all
Expression of Antibody–Drug Conjugate Targets in Urachal and Primary Bladder Adenocarcinomas. Clinical Genitourinary Cancer. https://www.sciencedirect.com/science/article/pii/S1558767326001904?dgcid=rss_sd_all
“Expression of Antibody–Drug Conjugate Targets in Urachal and Primary Bladder Adenocarcinomas.” Clinical Genitourinary Cancer.
@article{article41388,
title = {Expression of Antibody–Drug Conjugate Targets in Urachal and Primary Bladder Adenocarcinomas},
journal = {Clinical Genitourinary Cancer},
url = {https://www.sciencedirect.com/science/article/pii/S1558767326001904?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...